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Abstract 
This article presents the possibility of using of multiple regression analysis (MRA) and dyna-
mic neural network (DNN) for prediction of stability of Hydrocortisone 100 mg (in a form of
hydrocortisone sodium succinate) freeze-dried powder for injection packed into a dual
chamber container. Degradation products of hydrocortisone sodium succinate – free hyd-
rocortisone and related substances (impurities A, B, C, D and E; unspecified impurities and
total impurities) – were followed during stress and formal stability studies. All data ob-
tained during stability studies were used for in silico modeling; multiple regression models 
and dynamic neural networks as well, in order to compare predicted and observed results.
High values of coefficient of determination (0.95−0.99) were gained using MRA and DNN,
so both methods are powerful tools for in silico stability studies, but superiority of DNN
over mathematical modeling of degradation was also confirmed. 
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Hydrocortisone (HC), molecular weight 362.465, is a 
synthetic corticosteroid drug, (Figure 1) belonging to 
the group of corticosteroids, which are hydroxyl com-
pounds (alcohols). They are relatively insoluble in wa-
ter, and the sodium salt of the phosphate or succinate 
ester is generally used to provide water-soluble forms. 
Hydrocortisone hydrogen succinate (HC 21-HS) is 11β, 
17-dihydroxy-3,20-dioxopregn-4-en-21-yl hydrogen bu-
tanedioate (Figure 1) and it is usually used as active 
pharmaceutical ingredient. 
HC, like all corticosteroids, is an organic compound 
composed of a specifically condensed tetracyclic struc-
ture – a steroid structure and substituents. Considering 
the chemical structure of this compound, it has been 
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concluded that the most frequent reactions occur at 
the lateral dihydroxyacetone chain, as well as the trans-
esterifications between the positions C17 and C21. 
Gőrőg has described the process of intramolecular 
oxidoreduction of lateral dihydroxyacetone chain under 
the action of oxygen [1], as well as the sensitivity of 
acid and base to oxidation, depending on the present 
groups at C21 [2]. As early as in 1961, Herzog et al. [3] 
explained the changes occurring at C17 atom, whereby 
a small polar compound of enol aldehyde type is built 
in the process of dehydration. Di Giola et al. [4] have 
described the role of hydroxyl groups in the position 
C17 and C21 in the course of this reaction. The same 
associates have concluded that this substance of enol 
aldehyde type is synthesized as the mixture of E and Z 
isomers.  
HC and HC 21-HS are official in Ph. Eur. 7th (2011) 
[5], which presents impurities of HC and HC 21-HS. Spe-
cified impurities of HC 21-HS are free HC and Hydrocor-
             
Figure 1. Structural formulae of Hydrocortisone (HC) and Hydrocortisone-21-hydrogen succinate (HC 21-HS). 
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tisone acetate. Hydrocortisone acetate is a by-product 
that originates from synthesis and is not consider as 
degradation product.  
HC and its salts can be processed into different 
pharmaceutical dosage forms but they are very un-
stable substances, especially in the presence of mois-
ture. So, for their parenteral administration freeze-
dried pharmaceutical form must be used. A problem 
associated with this type of injection is the storage of 
the medications (powder and solution for reconstitu-
tion) that should be administered as separate com-
ponent parts and mixed prior to injection. Therefore, 
dual chamber vials have been developed to facilitate 
the storage and mixing of such two-component medi-
cations. This container closure system consists of a 
glass vial with two chambers separated by an inter-
mediate rubber closure and an upper closure on the 
top. The specific feature of this type of the products is 
that both the lyophilized active ingredient (in the lower 
chamber) and the solution for reconstitution (in the 
upper chamber) are in the same vial (Figure 2). 
 
Figure 2. Container closure system: A − dual chamber vial; 
B-intermediate closure; C − upper closure; D − plastic cap 
(plastic activator). 
The goal of this work was to follow the chemical 
stabilities of HC 100 mg freeze dried power packaged in 
dual chamber vial, as a specific container closure sys-
tem and to evaluate the possibility of using in silico me-
thod for prediction stability (multiple regression anal-
ysis and dynamic neural network). 
Multiple regression analysis 
Regression analysis is the branch of statistics that 
deals with the relationship (known as the regression 
function) between one variable y (dependent variable) 
and several others xi (independent variables). The reg-
ression function also involves a set of unknown para-
meters bi. If a regression function is linear in the para-
meters bi, it is known as a linear regression model. Fur-
thermore, if there is more than one independent vari-
able, it is called a multiple linear model. 
The general formula for multiple linear models is: 
yj = b0 + b1x1 + b2x2 +…+ bpxp, j = 1,2,…,n (1) 
with parameters defined as follows: p – number of 
independent variables; n – number of observations; y – 
dependent variables (predicted by a regression model); 
xi, i = 1,2,…,p – independent variables (predictors); bi, 
i = 1,2,…,p – regression coefficients; b0 – intercept 
(constant). 
The main objective of multiple linear regression 
analysis is to get the best set of parameters bi, so that 
the model predicts experimental values of the depen-
dent variable as accurately as possible (meaning that 
calculated values yj should be close to values yj*, j = 
= 1,2,…,n, obtained by experiment) [6]. 
Dynamic neural networks (DNNs) 
Dynamic neural networks (DNNs) are artificial neu-
ral networks used for the analysis of time series prob-
lems. Distinctions of DNNs are multiple presentations 
of inputs to the neural network allowing for the time 
dependent integration of inputs and outputs. Past in-
formation is used for the prediction of current and fu-
ture states of the analyzed system. The incorporation 
of time in the neural networks allows for the nonlinear 
process to be modelled more precisely with respect to 
static neural networks. Feedback of the signal is usually 
performed in the hidden layers of the network. A dyna-
mic neural network has the following characteristics: a 
high number of the degrees of freedom, i.e., possible 
connections between neurons, nonlinearity and the 
ability for dissipation [7]. Biological neurons also ex-
press dynamic behavior – apart from performing nonli-
near operations they are capable of some other dyna-
mic processes such as time delays, signal feedback and 
limit cycles [8]. Dynamic networks reportedly used for 
time series analysis are: memory neuron networks, 
dynamic neural unit, feedback networks and others [9]. 
A dynamic network stores long term memory struc-
ture in its feedback (recurrent) and regular connections 
whose weights are adjusted during training [10]. The 
most prominent characteristics of a memory in neural 
network are its depth and resolution [11]. DNNs are 
also referred to as recurrent neural networks. If a net-
work is fully recurrent, then every neuron receives in-
puts from every other neuron in the network. These 
networks are not arranged in the layers and still have 
not been widely employed due to their complexity.  
Dynamic neural networks have been employed as 
an alternative to the model-based approach for the 
prediction of drug dissolution profiles. The Elman recur-
rent network has been used to predict the dissolution 
profiles of a matrix controlled release theophylline pel-
let preparation [12]. Superiority of dynamic neural net-
works over static neural networks in modeling of time 
dependent drug dissolution from hydrophilic poly-
ethylene oxide matrices has been demonstrated [13]. 
Up to now there has been only one assessment of 
the possible usage of static neural networks to predict 
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the chemical degradation of drugs in stability studies 
[14]. Neural network modeling based on a back-pro-
pagation supervised learning algorithm has been em-
ployed to study the physical stability of lipophilic emul-
sions [15]. The generalized regression neural network 
model has been developed to assess the crystal purity 
of mebendazole raw material and to establish its phy-
sical stability in a suspension formulation [16]. The sta-
bility of the pellets and those of compressed tablets 
has been evaluated for degradation products under an 
accelerated stability protocol [17]. The data were anal-
yzed using a static multilayer perceptron neural net-
work and the only qualitative conclusions about the 
chemical degradation of the active substance could be 
withdrawn. The combined usage of the back-propaga-
tion neural network and a genetic algorithm has been 
utilized to design organic molecules presenting a speci-
fic biodegradability [18]. Genetic algorithms were intro-
duced by Holland [19], mimicking nature’s evolutionary 
method of adapting to a changing environment. They 
are stochastic optimization methods and provide po-
werful means to perform directed random searches in 
a problem space [20]. Genetic algorithms basically re-
present the population of the candidate solutions to 
the problem and if no optimum solution is found, a 
further generation of possible solutions is produced by 
selecting those solutions judged by some fitness crite-
ria [21]. 
In the present study, the feasibility of dynamic neu-
ral networks to predict the extent of drug degradation 
is demonstrated. The dynamic treatment of data is pos-
sible since the degradation of substances is a time de-
pendent process. Genetic algorithms are proposed as 
simple yet powerful optimization tools for the selection 
of an adequate dynamic network topology. The ob-
jective of the study is to propose the utilization of dy-
namic neural networks as in silico tools for the pre-
diction of the degree of drug degradation. 
EXPERIMENTAL 
Design of the stability study  
Stability testing is required for predicting the beha-
vior of the medicines during the time. Stability studies 
were designed through stress and formal stability test-
ing. 
Stress stability testing is usually performed in order 
to define the degradation profile and the kinetics of 
degradation of active substance and to define the in-
fluence of different factors such as temperature, humi-
dity, light etc., on the process of the degradation. In 
this work, stress studies were performed in order to 
collect results that could be used for statistical cal-
culation. During this phase, samples were treated under 
the conditions defined in Table 1. 
Table 1. Storage conditions and testing frequencies for stress 
stability testing; +: testing point at which the sample will be 
tested; –: testing point at which the sample won’t be tested 
Storage conditions, °C
Testing time points, days 
7 14 21 28 42 60 90 180
40 − − − + − + + − 
50 + + + + + + + + 
60 + + + + + + + + 
Generally speaking, formal stability testing has to be 
performed in accordance with relevant guidelines (ICH 
Q1A(R2), Guideline on Stability Testing: Stability Testing 
of Existing Active Substances and Related Finished 
Products, ICH Q1B [22–24] in order to establish or con-
firm the retest period of a drug substance or the shelf 
life of a drug product. Formal stability testing includes 
long-term and accelerated (and intermediate) studies. 
In this study, formal stability testing was performed in 
order to get results that could be used to confirm pre-
dicted values obtained with mathematical methods. 
Storage conditions and testing frequencies for formal 
stability testing are presented in Table 2. 
Table 2. Storage conditions and testing frequencies for formal 
stability testing 
Storage Conditions 
Testing time points, 
months 
Accelerated 40±2 °C/75±5% RH 0, 1, 2, 3 and 6 
Intermediate 30±2 °C/65±5% RH 0, 3, 6, 9 and 12 
Long-term 25±2 °C/60±5% RH 0, 3, 6, 9, 12, 18 and 24 
Some other stress testing (such as photostability 
testing) or formal (in use stability testing) tests were 
performed as well, but these results were not the 
scope of this article. 
During the study, the vials were kept in upright, as 
well as, in horizontal position. Since there was no dif-
ference, herein will be presented only results from 
samples stored in horizontal position. 
For determination of the analytes of interest vali-
dated high performance liquid chromatography (HPLC) 
methods were used.  
Materials 
This work was done on Hydrocortisone 100 mg 
powder for injections, in the form of freeze-dried pro-
duct in dual chamber vial. It is manufactured by Hemo-
farm, Vršac, Serbia. The solution for reconstitution is 
water for injection/ 0.9% benzyl alcohol. Two milliliters 
of reconstituted product contains hydrocortisone so-
dium succinate (HCNaS) equivalent to 100 mg HC. 
All samples were conditioned according to the re-
quirements of the International Conference on Harmo-
nization Standards for Stability (Q1A) and Photostability 
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(Q1B). The following chambers were used: Weiss 2000, 
Weiss Gallenkamp, Weiss 600, Weiss Gallenkamp, Sa-
nyo PSC 062, Sanyo Gallenkamp (Great Britain) and Weiss 
Umwelttechnik 140, Weiss Umwelttechnik, Germany. 
The solvents used were: n-butyl chloride (Merck, 
Germany), tetrahydrofuran (Sigma-Aldrich, Germany) 
methanol (Merck, Germany), glacial acetic acid (Sigma-
Aldrich, Germany), chloroform (Merck, Germany) and 
ortophosphoric acid (Merck, Germany) were of a grade 
suitable for high-performance liquid chromatography 
(HPLC) analysis. HC 21-HS (Aventis Pharma, France), HC 
and fluorometholone reference standards (RS) were 
obtained commercially. The reference standards were 
used without further purification. 
Analytical methods 
HPLC method for free HC determination  
Analytical procedure for the free HC determination 
was in accordance with USP 32 [25]. The concentration 
of free HC is separately expressed, as it is an important 
degradation product. The analyses were performed on 
an Agilent Technology 1100 Series HPLC system equip-
ped with 254 nm detector and column of porous silica 
particles packing (L3). The flow rate was 1.0 ml/min. 
Mobile phase was prepared by mixing n-butyl chloride, 
tetrahydrofuran, methanol and glacial acetic acid 
(95:7:3:3; v/v/v).  
Internal standard solution of concentration 3 mg/ml 
was obtained by dissolving the required amount of 
fluorometholone (RS) in tetrahydrofuran.  
HC solution. About 7.5 mg of HC RS was accurately 
weighed, transferred to a 25-ml volumetric flask and 
diluted with solvent to 25 ml. 
Solvent. 3% glacial acetic acid in chloroform. 
Standard solution. About 32.5 mg of HC 21-HS RS 
was weighed accurately and transferred to a 50-ml 
volumetric flask. 5 ml of internal standard solution and 
5 ml of HC 21-HS solution were added. Solvent was 
added up to 50 ml. 
Test solution. The tested product was reconstituted 
according to the manufacturer's directions. Aliquots of 
10 vials were collected and 1.0 ml of this solution was 
transferred to a volumetric flask of 100 ml. Internal 
standard solution was added (10 ml) and dissolved with 
solvent up to the mark. After 5 minute shaking, layers 
were separated and upper one was discarded. The in-
jection volume was 10 μl of each sample. 
HPLC method for determination of related substances  
Analytical procedure for the determination of the 
related substances was in accordance with internal 
HPLC isocratic method. The apparatus was Agilent 1100 
Series, with a variable wavelength UV–Vis detector. Se-
paration was performed on a Column C18 (250 mm×4.6 
mm, 5 µm), and the flow rate was 1.0 ml/min. The mo-
bile phase was prepared by combining acetonitrile, pu-
rified water and ortophosphoric acid (33:60:1, v/v/v) 
and diluted up to 1000 ml with purified water.  
Test solution. Reconstituted solutions prepared 
from the contents of 10 vials of HCNaS for injection 
were mixed, 1.0 ml was transferred to 50-ml volumetric 
flask and diluted with mobile phase up to 20 ml. Con-
centration of solution is 0.1 % w/v. 
Standard solution. 1 ml of test solution was trans-
ferred to a 100-ml volumetric flask and diluted with 
mobile phase. One ml of this solution was diluted with 
mobile phase to 10 ml. Concentration of standard so-
lution was 0.0001 % w/v. 
The injection volume was 10 μl of each sample. 
Multiple regression analysis 
Multiple regression analysis (Eq. (1)) was applied. 
The responses were: free HC, impurities A, B, C, D and E 
which were defined as degradation products due to the 
increasing concentration during the study; unspecified 
impurities and total amount of impurities. Predictors 
(independent variables) were: time (months), tempe-
rature (°C) and expressions of type timem×tempe-
raturen with m,n = 0,1,2… Regression models were ob-
tained in two steps.  
Step 1. A polynomial of degree 10 on time and tem-
perature was fitted to each of the responses. The fit 
quality was measured by the coefficient of determi-
nation, R2.  
Step 2. Models obtained in step 2 were improved by 
removing predictors (terms in the model) that are not 
statistically significant. This was done by performing a 
stepwise regression (removing a term that is least sta-
tistically significant or adding a term that is most sig-
nificant in each step, until one obtains an acceptable 
model).  
Expected levels of fit of all models were estimated 
by means of leave-one-out cross-validation technique. 
For each of the responses, one of the observations was 
removed from the sample (validation data), and the 
model was fitted to the rest of the sample (training 
data). This is repeated such that each observation is 
used once as validation data. Finally, as a measure of 
fit, coefficient of determination was computed. All 
calculations in this work were performed in MATLAB 
statistics toolbox. 
Dynamic neural network 
Commercially available Peltarion® software was 
used on a personal computer for designing the dynamic 
neural network. The topology of a DNN consists of 
blocks, information processing elements that are con-
nected with links. The links of hidden layer neurons are 
configured to have a memory of certain order, allowing 
for the input signal to be delayed for a predetermined 
number of steps. A pre-designed, built-in partial topo-
logy from the software has been used to construct an 
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adaptive system. The Recurrent One Layer dynamic 
network used in the study is represented in Figure 3. 
Data sources provide inputs and outputs to the net-
work.  
The inputs presented to the network were tempe-
rature and time whereas outputs were percent of free 
HC, impurities A, B, C, D and E; unspecified impurities 
and the total amount of impurities. The network was 
presented with the data obtained from stress stability 
protocols carried out at temperatures of 60, 50, 40 °C 
and from 30 °C, which is part of formal stability study. 
The data was divided on training and validation set. The 
ability of the network to predict the degree of degrada-
tion at 25 °C was evaluated in order to test the net-
work. The genetic optimizer algorithm was used in or-
der to improve the network architecture. The progress 
of errors for both training and validation sets were mo-
nitored during training to decide when to stop the 
training. When there were no more changes in the 
training error or when the validation error started to 
diverge, the training was stopped. 
 
Experimentally observed and in silico predicted frac-
tions of free HC, impurities A, B, C, D and E; unspecified 
impurities and total amount of impurities after specific 
time intervals were compared by the determination of 
coefficient of correlation r2. 
RESULTS AND DISCUSSION 
In accordance with USP 32 analytical procedure for 
the free HC determination was applied. Chromato-
grams of standard and test solutions are presented in 
Figures 4a and 4b, respectively. The order of the elu-
tion of peaks is: the internal standard peak (fluorome-
tholone), HC 21-HS peak and successive smaller peaks 
of free HC and hydrocortisone 17-hydrogen succinate 
(HC 17-HS).  
Chromatogram of related substances – impurities A, 
B, C, D and E, obtained by applying internal, validated 
HPLC method, is presented in Figure 5. 
By following the concentration it was noticed the 
growing of these five impurities. The increase in con-
centration of these impurities is proportional to the 
 
(a) 
 
(b) 
Figure 3. Representation of dynamic neural network: a) Peltarion® layout, b) schematic representation of the network. 
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temperature and time of conditioning, except impu-
rities C (the main product of photodegradation). The 
order of impurities, from the largest to the smallest 
concentration was as follow: B, then E, D and A. The 
change in concentration of impurity C was the least 
affected by temperature. 
The results of the concentration of free HC and re-
lated substances in stress testing are presented in Tab-
les 3 and 4, respectively. 
Those results were used for statistical analysis by 
applying methods of MRA and DNM. The results of the 
concentration of free HC and related substances in for-
mal testing are presented in Tables 5 and 6, respecti-
vely. 
Multiple regression analysis (MRA) modeling 
The results of the multiple regression analysis are 
presented in Table 7.  
High values of coefficient of determination (R2 from 
0.95 to 0.99) for impurities A, B, D and E indicate a 
good correlation between predicted and observed res- 
ponses. However, despite the fact that a good corre-
lation was observed, the main disadvantage of this me- 
thod is obvious: separate models for each response as
 
(a) 
 
(b) 
Figure 4. Chromatograms of standard (a) and test (b) solution. 
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Figure 5. Chromatogram of related substances – impurities A, B, C, D and E are considered as related substances − specified, 
unidentified impurities. 
Table 3. Concentration of free HC expressed as % of the declared Assay; stress testing; –: testing point at which the sample was not 
tested, in accordance with plan 
Storage condition, °C 
Testing time points, days 
0 7 14 21 28 42 60 90 180 
40 2.75 – – – 2.81 – 3.22 3.78 3.63 
50 2.75 3.11 3.25 3.27 3.52 3.66 3.81 3.95 5.01 
60 2.75 3.72 3.91 4.01 4.30 4.52 4.98 6.02 10.22 
Table 4. Concentrations of related substances (impurities) expressed as % of the declared Assay; stress testing; –:  testing point at 
which the sample was not tested, in accordance with plan 
t / °C Impurity 
Testing time points, days 
0 7 14 21 28 42 60 90 180 
40 A 0.03 − − − 0.03 − 0.04 0.06 0.10 
B 0.15 − − − 0.19 − 0.26 0.32 0.40 
C 0.03 − − − 0.05 − 0.06 0.08 0.10 
D 0.07 − − − 0.12 − 0.15 0.18 0.22 
E 0.11 − − − 0.16 − 0.20 0.25 0.31 
Single unspecified 0.02 − − − 0.02 − 0.05 0.03 0.06 
Total 0.80 − − − 0.85 − 1.32 1.19 1.82 
50 A 0.03 0.04 0.07 0.07 0.10 0.10 0.11 0.14 0.16 
B 0.15 0.23 0.34 0.34 0.38 0.41 0.48 0.58 0.77 
C 0.03 0.04 0.05 0.05 0.06 0.07 0.09 0.09 0.13 
D 0.07 0.15 0.18 0.20 0.22 0.24 0.26 0.27 0.37 
E 0.11 0.22 0.26 0.30 0.33 0.36 0.38 0.42 0.59 
Single unspecified 0.02 0.02 0.03 0.02 0.03 0.04 0.04 0.05 0.81 
Total 0.80 1.06 1.31 1.35 1.70 1.78 1.86 2.07 2.94 
60 A 0.03 0.09 0.13 0.16 0.19 0.20 0.22 0.34 0.69 
B 0.15 0.37 0.57 0.51 0.67 0.68 0.72 1.37 3.99 
C 0.03 0.06 0.07 0.08 0.09 0.09 0.13 0.17 0.23 
D 0.07 0.26 0.29 0.33 0.35 0.39 0.43 0.56 1.39 
E 0.11 0.38 0.46 0.52 0.58 0.63 0.68 0.94 2.43 
Single unspecified 0.02 0.04 0.04 0.06 0.07 0.08 0.09 0.11 0.49 
Total 0.80 1.62 2.09 2.11 2.44 2.68 2.89 4.32 11.1 
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Table 5. Concentration of free HC expressed as % of the declared assay; data obtained during formal stability testing; RH – relative 
humidity; –: testing point at which the sample was not tested, in accordance with plan 
Storage conditions 
Testing time points, months 
0 1 2 3 6 9 12 18 24 
40 °C/75% RH 2.75 2.81 3.22 3.58 3.63 − − − −
30 °C /65% RH 2.75 − − 3.22 2.98 3.25 3.30 − −
25 °C /60% RH 2.75 − − 3.06 2.83 3.04 3.20 3.30 3.37 
Table 6. Concentrations of related substances (impurities) expressed as % of the declared Assay; data obtained during formal 
stability testing; RH – relative humidity; –: testing point at which the sample was not tested, in accordance with plan 
t/RH Impurity 
Testing time points, months 
0 1 2 3 6 9 12 18 24 
40 °C/ 75% RH  A 0.03 0.03 0.04 0.06 0.10 – – – – 
B 0.15 0.19 0.26 0.32 0.40 – – – – 
C 0.03 0.05 0.06 0.08 0.10 – – – – 
D 0.07 0.12 0.15 0.18 0.22 – – – – 
E 0.11 0.16 0.20 0.25 0.31 – – – – 
Single unspecified 0.02 0.02 0.05 0.03 0.06 – – – – 
Total 0.80 0.85 1.32 1.19 1.82 – – – – 
30 °C/ 65% RH  A 0.03 – – 0.02 0.05 0.04 0.06 – – 
B 0.15 – – 0.21 0.24 0.26 0.30 – – 
C 0.03 – – 0.03 0.09 0.04 0.04 – – 
D 0.07 – – 0.08 0.11 0.14 0.16 – – 
E 0.11 – – 0.14 0.19 0.19 0.23 – – 
Single unspecified 0.02 – – 0.02 0.03 0.03 0.02 – – 
Total 0.80 – – 0.86 1.16 1.31 1.48 – – 
25 °C/ 60 % RH A 0.03 – – 0.02 0.04 0.05 0.04 0.05 0.07 
B 0.15 – – 0.21 0.24 0.25 0.29 0.31 0.36 
C 0.03 – – 0.04 0.08 0.06 0.07 0.08 0.06 
D 0.07 – – 0.09 0.10 0.12 0.16 0.18 0.20 
E 0.11 – – 0.12 0.16 0.19 0.23 0.26 0.29 
Single unspecified 0.02 – – 0.02 0.02 0.03 0.03 0.03 0.04 
Total 0.80 – – 0.92 1.13 1.39 1.56 1.51 1.65 
Table 7. Regression models obtained using multiple regression analysis; m – time (months); t – temperature (°C), b0–b26 – regression 
coefficients 
Response (y) Model R2 
Free HC y = b0+b1t+b2m
2t4+b3m
6t8 0.6556 
Impurity A y  = b0+b1t
2+b2mt
6+b3m
2t9+b4m
2t10+b5m
3t10+b6m
10 0.9911 
Impurity B y = b0+b1t
3+b2mt
3+b3mt
6+b4m
2t5+b5m
2t8+b6m
3t10 0.9631 
Impurity C y = b0+b1t
5 0.7361 
Impurity D y = b0+b1t
8+b2t
9+b3mt
3+b4mt
6+b5m
2t6+b6m
3t2+b7m
3t8 0.9781 
Impurity E y = b0+b1t
4+b2mt
6+b3mt
7+b4m
2t9+b5m
2t10+b6m
3t10 0.9784 
Single, unspecified  y = b0+b1t
2+b2mt
3+b3mt
4+b4mt
10 0.7497 
Total Impurities y = b0+b1t
3+b2mt
8+b3m
2 0.9444 
 
well as ponderous models. With such models it is hard 
to manipulate in terms of the simultaneous prediction 
of all impurities in the product (Table 7). 
Dynamic neural network (DNN) modeling 
The dynamic network consists of an input layer, one 
hidden layer and an output layer. From data source 1, 
the signal goes to the first Weight layer. The first 
weight layer has 2 inputs and 7 outputs. The number of 
outputs has been optimized using a Genetic Optimizer 
algorithm in the training mode of the program. From 
the first Weight layer, 7 outputs go to the first Function 
layer that has modified links and a feedback connection 
to itself. The developed dynamic network is a partially 
recurrent network since the recurrent connections are 
sent from the hidden layer back to itself. The recur-
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rence of signals is determined by the order of the link 
memory. Mandatory memory is added to the recurrent 
link as well as the interpolation parameter; weight μ. 
Local feedback is always scaled with 1−μ. For each of 
the 7 outputs there is a separate feedback μ1 to μ7; 
outputs were optimized using a Genetic Optimizer, 
making it possible to set up connections that can most 
adequately predict future states of the system. For si-
mulations used to construct dynamic network the num-
ber of populations was 200 and there were 1000 gene-
rations and 100 epochs. From the first, recurrent func-
tion layer, signal goes to second Weight layer that has 7 
inputs and 8 outputs (fractions of HC and impurities). 
From the second weight layer signals go to the second 
function layer. The second Function layer is an ordinary 
function layer (in comparison to the first function 
layer). It has 8 inputs and 8 outputs and performs Tanh 
sigmoid function. The function of the delta terminator 
is to compare two signals – the first signal comes from 
the data source 2 and represents real, observed out-
puts; whereas the second signal comes from the se-
cond function layer and represents outputs predicted 
by the dynamic system. A strong correlation between 
observed and predicted values of the amount of free 
HC, impurities A, B, C, D and E; unspecified impurities 
and a total amount of impurities has been obtained. 
Experimentally observed values and values predicted 
by DNN as well as correlation coefficients at specific 
time intervals are given in Tables 8 and 9. 
Correlation of predicted and obtained values after 
24 months for all tested parameters is presented in 
Figure 6. 
 
Figure 6. Correlation of experimental and predicted concen-
trations of HC, impurities A, B, C, D and E; unspecified im-
purities and total amount of impurities at 25 °C after 24 
months. 
The correlation between observed and predicted 
values is confirmed by r2 ranging from 0.9622 to 0.9910. 
The capability of DNN to predict the degree of degra-
dation was confirmed by comparing predicted and ex-
perimental data obtained by following degradation at 
25 °C after different time intervals (3, 6, 9 and 24 
months).  
It is important to emphasize that the ability of the 
network to accurately predict the degree of degra-
dation does not lessen with the increase of length of 
Table 8. Experimentally observed values and values predicted by DNN at specific time intervals;  ImpA, ImpB, ImpC, ImpD and ImpE 
are % of impurities A, B, C, D and E, respectively; unsp is percent of unspecified impurities and tot is percent of the total amount of 
impurities 
Time, months Value HC / % ImpA ImpB ImpC ImpD ImpE unsp tot 
3 Observed 3.060 0.02 0.21 0.04 0.06 0.12 0.02 0.92 
Predicted 3.020 0.02 0.05 0.03 0.04 0.08 0.03 0.72 
6 Observed 2.830 0.04 0.24 0.08 0.10 0.16 0.02 0.13 
Predicted 3.808 0.09 0.31 0.08 0.17 0.27 0.05 1.50 
9 Observed 3.040 0.05 0.25 0.06 0.12 0.19 0.03 1.39 
Predicted 3.690 0.08 0.34 0.08 0.17 0.26 0.04 1.47 
12 Observed 3.200 0.04 0.29 0.07 0.16 0.23 0.03 1.56 
Predicted 3.590 0.06 0.36 0.09 0.17 0.25 0.04 1.47 
18 Observed 3.300 0.05 0.31 0.08 0.18 0.26 0.03 1.51 
Predicted 3.618 0.06 0.30 0.09 0.19 0.27 0.04 1.55 
24 Observed 3.300 0.07 0.36 0.06 0.20 0.29 0.04 1.65 
Predicted 3.831 0.08 0.38 0.09 0.25 0.34 0.05 1.86 
Table 9. Coefficient of correlation of experimental and predicted values for specific time intervals 
Time, months 3 6 9 12 18 24 
Coefficient of correlation 0.9797 0.9910 0.9856 0.9622 0.9796 0.9876 
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time. This finding supports the usage of dynamic net-
works for predicting the stability of pharmaceutical 
products, i.e., shelf life.  
CONCLUSION 
It has been demonstrated that dynamic neural net-
works are powerful tools for in silico stability studies. 
When compared to the MRA modeling of HC degra-
dation, DNN shows superiority in terms of ease of ap-
plication and the handling of obtained results.  
With MRA models it is hard to manipulate in terms 
of the simultaneous prediction of all impurities in the 
product because the fact that every impurity requires 
its own models. On the other hand, DNN allows to set 
up connections between observed values and to get 
one network that can most adequately predict future 
states of the system. Furthermore, the ability of net-
work to accurately predict the degree of degradation is 
not affected by the time. 
By comparing predicted and experimental data it is 
confirmed that DNNs can be successfully used to pre-
dict the amount of drug degradation during storage, 
i.e., to predict the shelf life of the drug product.  
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IZVOD 
IN SILICO METODE U ISPITIVANJU STABILNOSTI HIDROKORTIZONA, LIOFILIZATA ZA INFUZIJU: VIŠESTRUKA 
REGRESIONA ANALIZA I DINAMIČKE NEURONSKE MREŽE 
Ljiljana N. Solomun1, Svetlana R. Ibrić2, Vjera M. Pejanović1, Jelena D. Đuriš2, Jelena M. Jocković2, 
Predrag D. Stankovic3, Zorica B. Vujić2 
1Hemofarm A.D., Vršac, Srbija 
2Univerzitet u Beogradu,Farmaceutski fakultet, Beograd, Srbija 
3Institut za otorinolaringologiju, Klinički centar Srbije, Beograd, Srbija 
(Naučni rad) 
Radi bezbednije, brže i efikasnije parenteralne primene hidrokortizona, široko
primenjivanog kortikosteroida, ispitivan je sistem kontaktnog pakovanja u kome
su i liofilizat i rastvor za rekonstituciju nalaze u jednoj, dvokomornoj bočici. Ispiti-
vanje je izvedeno na preparatu Hidrokortizon, 100 mg, liofilizat za rastvor za injek-
cije. Inicijalno postavljeni parametri kvaliteta su provereni prvo kroz studije stres
stabilnosti sa posebnim akcentom na promenu koncentracije slobodnog hidrokor-
tizona, odnosno definisanje degradacionog profila ispitivanog proizvoda. Ispiti-
vanje je vršeno pod uslovima povišene temperature (40 , 50 i 60 °C) u trajanju od 
tri, odnosno šest meseci. Rezultati su pokazali da dolazi do porasta koncentracije
slobodnog hidrokortizona u funkciji vremena i temperature. Takođe, detekovano 
je prisustvo pet degradacionih proizvoda. Dobijeni rezultati u toku stres ispitivanja
stabilnosti su korišćeni u statističkim proračunima. Potvrda kako definisanog kvali-
teta proizvoda, tako i predvidjanja stabilnosti korišćenjem in silico metoda dobi-
jena je kroz ispitivanje stabilnosti metodom formalnog ispitivanja, pod uslovima
ubrzanog (40 °C/75% RH), intermedijernog (30 °C/65% RH) i dugotrajnog starenja
(25 °C/60% RH). Tokom ispitivanja detektuje se porast koncentracije slobodnog
hidrokortizona, ali i srodnih supstanci (nečistoća) koje se javljaju pod uticajem 
temperature (nečistoće A, B, D i E), odnosno C koja je proizvod fotodegradacije.
Ovi degradacioni proizvodi nastaju intramolekulskim premeštanjima. U opisivanju
brzine degradacije hidrokortizona, korišćene su metode multiple regresione ana-
lize (MRA) i dinamičke neuronske mreže (DNM), a dobijeni rezultati su poređeni 
sa rezultatima ispitivanja uzorka pod uslovima ubrzanog i dugotrajnog starenja.
Primenom MRA dobijene su visoke vrednosti koeficijenta korelacije (R2 od 0,95 do 
0,99) osim za slobodni hidrokortizon (0,65), nečistoću C (0,73) i slobodne nespeci-
ficirane (0,74), što pokazuje da postoji dobra korelacija između predviđenih i eks-
perimentalno dobijenih odgovora. Kada je primenjena neuronska mreža tipa
RJDM, visoke vrednosti koeficijenta korelacije (od 0,96 do 0,99) pokazuju da je 
mreža obučena da predvidi stepen degradacije hidrokortizona na 25 oC u različitim 
vremenskim intervalima. Dobijeni rezultati pokazuju da se obe in silico metode 
mogu uspešno koristiti u predviđanju procenta nečistoća i brzine degradacije leko-
vitih supstanci. Prednost korišćenja neuronskih mreža je što je sa njom moguće
istovremeno manipulisati sa svim odgovorima (tj. nečistoćama), tj. vrlo jedno-
stavno, jednom kada je mreža istrenirana, predvideti koncentracije svih nečistoća 
ispitivanih preparata na bilo kojoj temperaturi i u bilo kom vremenu.
  Ključne reči: Hidrokortizon • Stabilnost •
Višestruka regresiona analiza • Dinamič-
ke neuronske mreže 
 
